Cargando…

Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations

INTRODUCTION: Systemic inflammatory response syndrome (SIRS) is a frequent condition after cardiopulmonary bypass (CPB) and makes conventional biological tests fail to detect postoperative sepsis. Biphasic waveform (BPW) analysis is a new biological test derived from activated partial thromboplastin...

Descripción completa

Detalles Bibliográficos
Autores principales: Delannoy, Bertrand, Guye, Marie-Laurence, Slaiman, Davy Hay, Lehot, Jean-Jacques, Cannesson, Maxime
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811936/
https://www.ncbi.nlm.nih.gov/pubmed/19912638
http://dx.doi.org/10.1186/cc8166
_version_ 1782176815304933376
author Delannoy, Bertrand
Guye, Marie-Laurence
Slaiman, Davy Hay
Lehot, Jean-Jacques
Cannesson, Maxime
author_facet Delannoy, Bertrand
Guye, Marie-Laurence
Slaiman, Davy Hay
Lehot, Jean-Jacques
Cannesson, Maxime
author_sort Delannoy, Bertrand
collection PubMed
description INTRODUCTION: Systemic inflammatory response syndrome (SIRS) is a frequent condition after cardiopulmonary bypass (CPB) and makes conventional biological tests fail to detect postoperative sepsis. Biphasic waveform (BPW) analysis is a new biological test derived from activated partial thromboplastin time that has recently been proposed for sepsis diagnosis. The aim of this study was to investigate the accuracy of BPW to detect sepsis after cardiac surgery under CPB. METHODS: We conducted a prospective study in American Society of Anesthesiologists' (ASA) physical status III and IV patients referred for cardiac surgery under CPB. Procalcitonin (PCT) and BPW were recorded before surgery and every day during the first week following surgery. Patients were then divided into three groups: patients presenting no SIRS, patients presenting with non-septic SIRS and patients presenting with sepsis. RESULTS: Thirty two patients were included. SIRS occurred in 16 patients (50%) including 5 sepsis (16%) and 11 (34%) non-septic SIRS. PCT and BPW were significantly increased in SIRS patients compared to no SIRS patients (0.9 [0.5-2.2] vs. 8.1 [2.0-21.3] ng/l for PCT and 0.10 [0.09-0.14] vs. 0.29 [0.16-0.56] %T/s for BPW; P < 0.05 for both). We observed no difference in peak PCT value between the sepsis group and the non-septic SIRS group (8.4 [7.5-32.2] vs. 7.8 [1.9-17.5] ng/l; P = 0.67). On the other hand, we found that BPW was significantly higher in the sepsis group compared to the non-septic SIRS group (0.57 [0.54-0.78] vs. 0.19 [0.14-0.29] %T/s; P < 0.01). We found that a BPW threshold value of 0.465%T/s was able to discriminate between sepsis and non-septic SIRS groups with a sensitivity of 100% and a specificity of 93% (area under the curve: 0.948 +/- 0.039; P < 0.01). Applying the previously published threshold of 0.25%T/s, we found a sensitivity of 100% and a specificity of 72% to discriminate between these two groups. Neither C-reactive protein (CRP) nor PCT had significant predictive value (area under the curve for CRP was 0.659 +/- 0.142; P = 0.26 and area under the curve for PCT was 0.704 +/- 0.133; P = 0.15). CONCLUSIONS: BPW has potential clinical applications for sepsis diagnosis in the postoperative period following cardiac surgery under CPB.
format Text
id pubmed-2811936
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28119362010-01-28 Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations Delannoy, Bertrand Guye, Marie-Laurence Slaiman, Davy Hay Lehot, Jean-Jacques Cannesson, Maxime Crit Care Research INTRODUCTION: Systemic inflammatory response syndrome (SIRS) is a frequent condition after cardiopulmonary bypass (CPB) and makes conventional biological tests fail to detect postoperative sepsis. Biphasic waveform (BPW) analysis is a new biological test derived from activated partial thromboplastin time that has recently been proposed for sepsis diagnosis. The aim of this study was to investigate the accuracy of BPW to detect sepsis after cardiac surgery under CPB. METHODS: We conducted a prospective study in American Society of Anesthesiologists' (ASA) physical status III and IV patients referred for cardiac surgery under CPB. Procalcitonin (PCT) and BPW were recorded before surgery and every day during the first week following surgery. Patients were then divided into three groups: patients presenting no SIRS, patients presenting with non-septic SIRS and patients presenting with sepsis. RESULTS: Thirty two patients were included. SIRS occurred in 16 patients (50%) including 5 sepsis (16%) and 11 (34%) non-septic SIRS. PCT and BPW were significantly increased in SIRS patients compared to no SIRS patients (0.9 [0.5-2.2] vs. 8.1 [2.0-21.3] ng/l for PCT and 0.10 [0.09-0.14] vs. 0.29 [0.16-0.56] %T/s for BPW; P < 0.05 for both). We observed no difference in peak PCT value between the sepsis group and the non-septic SIRS group (8.4 [7.5-32.2] vs. 7.8 [1.9-17.5] ng/l; P = 0.67). On the other hand, we found that BPW was significantly higher in the sepsis group compared to the non-septic SIRS group (0.57 [0.54-0.78] vs. 0.19 [0.14-0.29] %T/s; P < 0.01). We found that a BPW threshold value of 0.465%T/s was able to discriminate between sepsis and non-septic SIRS groups with a sensitivity of 100% and a specificity of 93% (area under the curve: 0.948 +/- 0.039; P < 0.01). Applying the previously published threshold of 0.25%T/s, we found a sensitivity of 100% and a specificity of 72% to discriminate between these two groups. Neither C-reactive protein (CRP) nor PCT had significant predictive value (area under the curve for CRP was 0.659 +/- 0.142; P = 0.26 and area under the curve for PCT was 0.704 +/- 0.133; P = 0.15). CONCLUSIONS: BPW has potential clinical applications for sepsis diagnosis in the postoperative period following cardiac surgery under CPB. BioMed Central 2009 2009-11-13 /pmc/articles/PMC2811936/ /pubmed/19912638 http://dx.doi.org/10.1186/cc8166 Text en Copyright ©2009 Delannoy et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Delannoy, Bertrand
Guye, Marie-Laurence
Slaiman, Davy Hay
Lehot, Jean-Jacques
Cannesson, Maxime
Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
title Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
title_full Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
title_fullStr Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
title_full_unstemmed Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
title_short Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
title_sort effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and c-reactive protein concentrations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811936/
https://www.ncbi.nlm.nih.gov/pubmed/19912638
http://dx.doi.org/10.1186/cc8166
work_keys_str_mv AT delannoybertrand effectofcardiopulmonarybypassonactivatedpartialthromboplastintimewaveformanalysisserumprocalcitoninandcreactiveproteinconcentrations
AT guyemarielaurence effectofcardiopulmonarybypassonactivatedpartialthromboplastintimewaveformanalysisserumprocalcitoninandcreactiveproteinconcentrations
AT slaimandavyhay effectofcardiopulmonarybypassonactivatedpartialthromboplastintimewaveformanalysisserumprocalcitoninandcreactiveproteinconcentrations
AT lehotjeanjacques effectofcardiopulmonarybypassonactivatedpartialthromboplastintimewaveformanalysisserumprocalcitoninandcreactiveproteinconcentrations
AT cannessonmaxime effectofcardiopulmonarybypassonactivatedpartialthromboplastintimewaveformanalysisserumprocalcitoninandcreactiveproteinconcentrations